HRT Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,616
| Closed | -$536K | – | 2830 |
|
|
2021
Q4 | $536K | Buy |
+6,616
| New | +$536K | ﹤0.01% | 1497 |
|
|
2021
Q3 | – | Sell |
-11,926
| Closed | -$1.18M | – | 3007 |
|
|
2021
Q2 | $1.18M | Sell |
11,926
-6,796
| -36% | -$670K | 0.01% | 869 |
|
|
2021
Q1 | $1.57M | Sell |
18,722
-21,354
| -53% | -$1.79M | 0.02% | 650 |
|
|
2020
Q4 | $3.46M | Buy |
40,076
+15,022
| +60% | +$1.3M | 0.07% | 199 |
|
|
2020
Q3 | $1.76M | Buy |
+25,054
| New | +$1.76M | 0.05% | 261 |
|
|
2020
Q2 | – | Sell |
-38,720
| Closed | -$1.79M | – | 1409 |
|
|
2020
Q1 | $1.79M | Sell |
38,720
-13,336
| -26% | -$617K | 0.12% | 155 |
|
|
2019
Q4 | $3.21M | Buy |
52,056
+36,463
| +234% | +$2.25M | 0.14% | 109 |
|
|
2019
Q3 | $663K | Buy |
15,593
+10,513
| +207% | +$447K | 0.03% | 451 |
|
|
2019
Q2 | $263K | Buy |
+5,080
| New | +$263K | 0.02% | 554 |
|
|
2018
Q3 | – | Sell |
-4,516
| Closed | -$258K | – | 365 |
|
|
2018
Q2 | $258K | Buy |
+4,516
| New | +$258K | 0.09% | 153 |
|
|
2017
Q1 | – | Sell |
-10,360
| Closed | -$413K | – | 125 |
|
|
2016
Q4 | $413K | Buy |
+10,360
| New | +$413K | 0.53% | 29 |
|
|
2016
Q3 | – | Sell |
-9,694
| Closed | -$376K | – | 117 |
|
|
2016
Q2 | $376K | Buy |
+9,694
| New | +$376K | 0.23% | 58 |
|